Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, and Steroid Sparing Effect of Acthar in Patients With Hematologic Manifestations of Systemic Lupus Erythematosus

NCT02779153 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02779153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02779153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, and Steroid Sparing Effect of Acthar in Patients With Hematologic Manifestations of Systemic Lupus Erythematosus
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2016
Completion date
May 22, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

repository corticotropin injection, systemic lupus erythematosus (sle)